Investigating a new gene linked to metabolic syndrome and diabetes
The characterization of Cela2a, a novel disease gene for metabolic syndrome in health and diseases
This study is looking at a gene called CELA2A to see how changes in it might affect insulin resistance and related health problems, with the hope of finding better treatments for people with type 2 diabetes and metabolic syndrome.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11059201 on NIH RePORTER |
What this research studies
This research focuses on understanding the CELA2A gene, which has been linked to metabolic syndrome and type 2 diabetes. By studying how mutations in this gene affect insulin resistance and related health issues, the research aims to uncover new therapeutic opportunities. The approach includes analyzing the gene's role in insulin secretion and sensitivity, as well as its effects on other metabolic pathways. Patients may benefit from insights that could lead to improved treatments for diabetes and cardiovascular diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with metabolic syndrome, type 2 diabetes, or a family history of these conditions.
Not a fit: Patients without metabolic syndrome or type 2 diabetes, or those with unrelated health issues, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve insulin sensitivity and reduce the risk of type 2 diabetes and related cardiovascular diseases.
How similar studies have performed: Previous research has shown promising results in understanding genetic factors related to metabolic syndrome, indicating potential for success in this area.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Mani, Arya — Yale University
- Study coordinator: Mani, Arya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.